Literature DB >> 2667940

Inflammatory processes in bronchial asthma.

R Beasley1, W Roche, S T Holgate.   

Abstract

Bronchial asthma is an inflammatory disease. The characteristic pathological features of epithelial cell loss, goblet cell hyperplasia, increased deposition of collagen beneath the basement membrane, mast cell degranulation, and inflammatory cell infiltration of the mucosa are not limited to fatal asthma. Similar inflammatory events have been observed in subjects who would be considered to have clinically stable asthma. These observations would suggest that pharmacological treatment directed against the underlying inflammatory processes in asthma should not be limited to those patients with severe forms of the disease.

Entities:  

Mesh:

Year:  1989        PMID: 2667940     DOI: 10.2165/00003495-198900371-00021

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  14 in total

1.  The pathology of asthma, with special reference to changes in the bronchial mucosa.

Authors:  M S DUNNILL
Journal:  J Clin Pathol       Date:  1960-01       Impact factor: 3.411

2.  A clinical and pathological study of fatal cases of status asthmaticus.

Authors:  J C HOUSTON; S DE NAVASQUEZ; J R TROUNCE
Journal:  Thorax       Date:  1953-09       Impact factor: 9.139

3.  The shedding of the mucosa of the bronchial tree in asthma.

Authors:  B NAYLOR
Journal:  Thorax       Date:  1962-03       Impact factor: 9.139

4.  Anatomopathologic changes in the bronchial walls in chronic inflammation, with special reference to the basement membrane, in the course of bronchial asthma.

Authors:  J Nowak
Journal:  Acta Med Pol       Date:  1969

5.  The eosinophilic leukocyte and the pathology of fatal bronchial asthma: evidence for pathologic heterogeneity.

Authors:  G J Gleich; S Motojima; E Frigas; G M Kephart; T Fujisawa; L P Kravis
Journal:  J Allergy Clin Immunol       Date:  1987-09       Impact factor: 10.793

6.  Ultrastructure of airways in children with asthma.

Authors:  E Cutz; H Levison; D M Cooper
Journal:  Histopathology       Date:  1978-11       Impact factor: 5.087

7.  Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases.

Authors:  P J Dor; S J Ackerman; G J Gleich
Journal:  Am Rev Respir Dis       Date:  1984-12

8.  Cellular events in the bronchi in mild asthma and after bronchial provocation.

Authors:  R Beasley; W R Roche; J A Roberts; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1989-03

9.  Damage of the airway epithelium and bronchial reactivity in patients with asthma.

Authors:  L A Laitinen; M Heino; A Laitinen; T Kava; T Haahtela
Journal:  Am Rev Respir Dis       Date:  1985-04

10.  Terfenadine (Seldane) is a potent and selective histamine H1 receptor antagonist in asthmatic airways.

Authors:  P Rafferty; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1987-01
View more
  4 in total

Review 1.  Type 2 inflammation in asthma--present in most, absent in many.

Authors:  John V Fahy
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

Review 2.  Stratified approaches to the treatment of asthma.

Authors:  Stephen T Holgate
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

3.  Relationship between 25-hydroxyvitamin D levels and inflammatory factors in children with asthma attack.

Authors:  Shang Wang; Yao Pan; Zhenkun Zhang
Journal:  Exp Ther Med       Date:  2018-03-27       Impact factor: 2.447

4.  Increased Ratio of Matrix Metalloproteinase-9 (MMP-9)/Tissue Inhibitor Metalloproteinase-1 from Alveolar Macrophages in Chronic Asthma with a Fast Decline in FEV1 at 5-Year Follow-up.

Authors:  Fu-Tsai Chung; Hung-Yu Huang; Chun-Yu Lo; Yu-Chen Huang; Chang-Wei Lin; Chih-Chen He; Jung-Ru He; Te-Fang Sheng; Chun-Hua Wang
Journal:  J Clin Med       Date:  2019-09-12       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.